Barr, FDA Will Meet On Plan B Switch; Agency Says Rulemaking Not Needed

The approval process for the over-the-counter sale of Barr's emergency contraceptive Plan B could be "wrapped up in a matter of weeks if [Barr and FDA] work diligently" together, according to an FDA spokesperson

More from Archive

More from Pink Sheet